The establishment of potential cerebrospinal fluid biomarkers for canine degenerative myelopathy

Shafie, Intan Nur Fatiha (2013) The establishment of potential cerebrospinal fluid biomarkers for canine degenerative myelopathy. PhD thesis, University of Glasgow.

Full text available as:
[thumbnail of 2013ShafiePhD.pdf] PDF
Download (8MB)
Printed Thesis Information:


Canine degenerative myelopathy(DM) is a late onset neurodegenerative disease that primarily affects German Shepherd dog (GSD), though a number of other specific breeds
are also affected. The underlying cause of the disorder remains elusive, though recent advances have implicated a mutation of superoxide dismutase 1(Sod1) in the aetiology, also implying DM is a potential orthologue of human amyotrophic lateral sclerosis. The identification of the Sod1 mutation raises the index of suspicion for an individual animal, however it is not specifically diagnostic as a proportion of dogs homozygous for the Sod1 mutation do not develop DM. Therefore, there is a clinical need for the development of specific biomarker(s) for DM to support genetic test. The aim of this study was to establish potential biomarkers for DM by exploring canine cerebrospinal fluid (CSF). A dual strategy was adopted;1) Evaluation of potential ALS biomarkers in DM CSF, 2) Identification of novel biomarker(s) in DM CSF. The cases selected in this project had a presumptive diagnosis of DM and were homozygous for Sod1 mutation. Preliminary characterisation by Western blot and mass spectrometry identified four protein candidates in DM CSF, comprised of cystatin C, transthyretin (dimeric and monomeric TTR), haptoglobin and clusterin. Since the validity of these putative biomarkers may be influenced by pre-analytical variables that may arise from the clinical environment, we therefore assessed the impact of three potential sample handling practices on these four proteins. The results from these experiments demonstrate that dimeric TTR and clusterin were affected by sample handling conditions. Therefore, an appropriate protocol for CSF sample handling was established. Western blot analyses indicated that clusterin is the most viable biomarker candidate for DM. Clusterin was significantly elevated in DM CSF when compared to a range of neurological conditions. The second potential candidate for DM biomarker is TTR, which is potentially reduced, an observation similar to those found in ALS CSF. The relationship of these proteins in the pathogenic mechanisms that underpin DM is unclear. However,
based on observations on ALS, it is reasonable to speculate that their alterations are associated with a toxic gain of function of the mutant SOD1 protein. The successful
characterisation of clusterin and TTR in DM CSF may therefore represent components of a panel of emerging biomarkers that may combine to distinguish DM in the clinic and provide further insights into the disease mechanisms.

Item Type: Thesis (PhD)
Qualification Level: Doctoral
Keywords: Canine degenerative myelopathy, German Shepherd dog, amyotrophic lateral sclerosis, superoxide dismutase 1 gene mutation, protein biomarkers
Subjects: S Agriculture > SF Animal culture > SF600 Veterinary Medicine
Colleges/Schools: College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine > Small Animal Clinical Sciences
Supervisor's Name: Anderson, Prof. Thomas James and McLaughlin, Dr. Mark
Date of Award: 2013
Depositing User: Dr. Intan N.F. Shafie
Unique ID: glathesis:2013-4292
Copyright: Copyright of this thesis is held by the author.
Date Deposited: 30 May 2013 09:27
Last Modified: 30 May 2013 10:40

Actions (login required)

View Item View Item


Downloads per month over past year